There’s certainly enough opportunity during times of a bull market to take a “buy low, sell high” strategy. When it comes to increased gain potential, investors and day traders alike will turn to more volatile investments. These include futures trading, options trading, and even penny stock trading. Without having to learn strategy and rely on formulas, penny stocks by far have been a simpler investment option when it comes to capitalizing on the market’s positive momentum. Companies like Enviro-Serv Inc(OTCMKTS:EVSV), Acura Pharmaceuticals, Inc.(NASDAQ:ACUR), and GTx, Inc.(NASDAQ:GTXI) have all seen recent price and volume spikes due to news and corporate announcements.
Enviro-Serv has been working to gain exposure within the pest control space specifically within the State of Florida. Following the announcements that the company has successfully obtained the capital to firm up final negotiations for the Pestmaster Services franchise for the Tampa Bay area, Enviro-Serv’s subsidiary, Xterminate, could soon be able to operate as Pestmaster Tampa. This arrangement is slated to allow Enviro-Serv through Xterminate to take advantage of the relationships the Pestermaster brand has in place with larger organizations like those relating to federal opportunities. The Company anticipates closing the agreement on or before June 30th. With much more anticipation, stock price has spiked from $0.0007 to highs of $0.0012. During the course of the last 45 days, shares of EVSV have rallied as much as 650%.
Acura Pharmaceuticals has found an increase in trading momentum after making several of its own announcements as well. Most notably, on Tuesday the Company announced that the Company entered into a License and Development Agreement with Bayer Healthcare (OTCMKTS:BAYRY) to provide an exclusive worldwide license to Acura’s IMPEDE technology. It will be used in an undisclosed methamphetamine resistant pseudoephedrine containing product and to jointly develop such product utilizing the IMPEDE technology for the U.S. market. Upon making the announcement, shares of ACUR skyrocketed to highs of $1.35, up 62.7% from Monday’s close of $0.83. Bob Jones, Acura’s President and CEO, commented, “We’re excited to have a partner that brings highly valued development expertise and is committed to addressing the methamphetamine problem.”
GTX, Inc. has seen a consistent uptrend in price over more recent months. Following a period of sideways trading during the first 5 months of the year, shares of GTXI have begun to climb. The company regained compliance with NASDAQ regarding its minimum bid price of $1 earlier in June at which point GTX was already in an uptrend. “During the past year, we have refocused our operations primarily on two important opportunities in metastatic breast cancer, and we have raised additional capital to support our operations. Importantly, we also have made a key hire with the appointment of Dr. Rob Wills as Executive Chairman,” said Marc S. Hanover, CEO of GTx.
So far shares have climbed by as much as 143% from lows of $0.60 in February to recent highs of $1.46 on Tuesday.